Literature DB >> 2306575

Factor VIII related antigen in connective tissue disease patients and relatives.

J P James1, T R Stevens, N D Hall, P J Maddison, N J Goulding, A Silman, S Holligan, C Black.   

Abstract

This study assayed serum levels of FVIII Rag as a marker of endothelial injury in patients not only with frank connective tissue disease but also in those presenting with Raynaud's phenomenon and in families of those with systemic sclerosis. Elevated levels of FVIII Rag were found in 62% of patients with systemic sclerosis (SS), 38% with systemic lupus erythematosus (SLE), 67% with mixed connective tissue disease (MCTD) and in 17% with primary Raynaud's phenomenon. Twenty per cent of first degree relatives of patients with SS also demonstrated high levels of FVIII Rag and certain antibodies, namely those reacting with U1RNP and the centromere. The association between elevated FVIII Rag and antibodies linked to Raynaud's and vasculitis lends support to antibody involvement in pathogenesis. High levels of FVIII Rag in family members may reflect an increased susceptibility of endothelium to injury particularly since relatives also have a higher frequency of clinical features such as Raynaud's phenomenon.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2306575     DOI: 10.1093/rheumatology/29.1.6

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  5 in total

Review 1.  Raynaud's phenomenon: epidemiology and risk factors.

Authors:  Liana Fraenkel
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

2.  Circulating von Willebrand factor in inflammatory bowel disease.

Authors:  T R Stevens; J P James; N J Simmonds; D A McCarthy; I F Laurenson; P J Maddison; D S Rampton
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

3.  Damage to the endothelium in Sjögren's syndrome: lack of correlation with antinuclear antibody titre and presence of antibodies to SSA or SSB autoantigens.

Authors:  A D Blann; A C Wainwright; P Emery
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

4.  Anti-endothelial cell antibodies in inflammatory bowel disease.

Authors:  T R Stevens; S L Harley; J S Groom; G Cambridge; B Leaker; D R Blake; D S Rampton
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

Review 5.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.